Skip to content
ResultsThird-quarter 2026 results — read the letter to shareholders

Cold chains with a history

Veranth Pharma on watching every reefer in 31 markets.

What it found.

−62%cold-chain excursions
99.4%shipments in range on arrival
1,140cold-chain lanes watched

In brief

Dr. Amara Okafor, Veranth's SVP Global Supply, and Helden's life-sciences team on how a temperature history for every shipment changed what the quality team does at 2 a.m.

Watch the webinar.

Sent to your inbox — no further steps, and no call unless you ask for one.

The report is on its way to your inbox. It arrives as a PDF within a few minutes.
It did not send.